Price $64.64 |
Market Cap
12.89B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
47.6
|
P/B
11.81
|
P/S
5.38
|
Dividend %
0.20%
|
|
P/CF
-
|
P/FCF
56.1
|
Op. Cash Flow
346.8K
|
FCF
1.5
|
|
Op. Margin
17.00%
|
Net Margin
11.40%
|
ROE
27.00%
|
ROI
10.20%
|
|
ROA
8.80%
|
EPS Growth
73.70%
|
Current Ratio
2.4
|
Debt/Equity
87.60%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Surgalign Holdings Inc (SRGA) | $0.69 | - | - | 100.6M | Strong Buy |
| Mediwound Ltd (MDWD) | $2.46 | - | - | 67.3M | Strong Buy |
| Endo International PLC (ENDP) | $3.18 | - | - | 923M | Strong Buy |
| Cannabis Sativa Inc (CBDS) | $0.20 | - | - | 6M | Strong Buy |
| Recro Pharma Inc (REPH) | $1.56 | - | - | 68.5M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
